NASDAQ:BCRX - BioCryst Pharmaceuticals SEC Filings & 10K Form

Sign in or create an account to add this stock to your watchlist.
$8.26 -0.33 (-3.84 %)
(As of 12/14/2018 04:00 PM ET)
Previous Close$8.26
Today's Range$8.18 - $8.75
52-Week Range$4.25 - $9.70
Volume504,429 shs
Average Volume731,640 shs
Market Capitalization$941.82 million
P/E Ratio-10.59
Dividend YieldN/A
Beta1.78

SEC Filings

BioCryst Pharmaceuticals (NASDAQ:BCRX) SEC Filings

DateFilerForm TypeView
12/12/2018
3:13 PM
BioCryst Pharmaceuticals (Issuer)
Powell Lynne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/06/2018
3:34 PM
BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/06/2018
3:30 PM
BioCryst Pharmaceuticals (Issuer)
STAAB THOMAS R II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/06/2018
3:27 PM
BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/06/2018
8:13 AM
BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
12/04/2018
3:11 PM
Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/30/2018
3:02 PM
BioCryst Pharmaceuticals (Issuer)
Erck Stanley C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/26/2018
3:22 PM
BioCryst Pharmaceuticals (Issuer)
Powell Lynne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/26/2018
3:19 PM
BioCryst Pharmaceuticals (Issuer)
STAAB THOMAS R II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/21/2018
3:51 PM
BioCryst Pharmaceuticals (Issuer)
Powell Lynne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/21/2018
3:48 PM
BioCryst Pharmaceuticals (Issuer)
STAAB THOMAS R II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/20/2018
6:29 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/09/2018
3:14 PM
BioCryst Pharmaceuticals (Issuer)
STAAB THOMAS R II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/09/2018
3:11 PM
BioCryst Pharmaceuticals (Issuer)
Powell Lynne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/09/2018
10:47 AM
BioCryst Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
11/08/2018
2:15 PM
BioCryst Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
11/07/2018
3:05 PM
BioCryst Pharmaceuticals (Issuer)
Powell Lynne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/07/2018
3:03 PM
BioCryst Pharmaceuticals (Issuer)
STAAB THOMAS R II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/06/2018
3:07 PM
BioCryst Pharmaceuticals (Issuer)
Powell Lynne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/06/2018
3:04 PM
BioCryst Pharmaceuticals (Issuer)
STAAB THOMAS R II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/06/2018
7:20 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/05/2018
12:17 PM
BioCryst Pharmaceuticals (Issuer)
Powell Lynne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/31/2018
8:37 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/23/2018
12:34 PM
BioCryst Pharmaceuticals (Issuer)
STAAB THOMAS R II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/23/2018
12:31 PM
BioCryst Pharmaceuticals (Issuer)
Powell Lynne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/04/2018
12:09 PM
BioCryst Pharmaceuticals (Issuer)
STAAB THOMAS R II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/28/2018
3:25 PM
BioCryst Pharmaceuticals (Filer)
Form DEF 14A
View Filing
09/18/2018
3:00 PM
BioCryst Pharmaceuticals (Filer)
Form PRE 14A
View Filing
09/17/2018
6:41 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
09/06/2018
6:55 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
09/04/2018
12:00 PM
BioCryst Pharmaceuticals (Filer)
Form 8-K/A
View Filing
09/04/2018
6:28 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/13/2018
9:07 AM
BioCryst Pharmaceuticals (Issuer)
Sheridan William P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/09/2018
1:19 PM
BioCryst Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
08/07/2018
6:31 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/06/2018
3:30 PM
BioCryst Pharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13G/A
View Filing
08/06/2018
11:10 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/06/2018
7:00 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/01/2018
3:02 PM
BioCryst Pharmaceuticals (Filer)
Form 424B5
View Filing
07/31/2018
3:00 PM
BioCryst Pharmaceuticals (Subject)
GREAT POINT PARTNERS LLC (Filed by)
Form SC 13D/A
View Filing
07/20/2018
2:49 PM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/11/2018
7:11 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/10/2018
3:18 PM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/10/2018
2:59 PM
BioCryst Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
View Filing
06/22/2018
8:40 AM
BioCryst Pharmaceuticals (Issuer)
LEE KENNETH B JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/22/2018
8:38 AM
BioCryst Pharmaceuticals (Issuer)
INGRAM ROBERT ALEXANDER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/22/2018
8:35 AM
BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/22/2018
8:32 AM
BioCryst Pharmaceuticals (Issuer)
Erck Stanley C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/22/2018
8:29 AM
BioCryst Pharmaceuticals (Issuer)
Cohen Fred E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/22/2018
8:25 AM
ABERCROMBIE GEORGE B (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/21/2018
5:06 AM
BioCryst Pharmaceuticals (Subject)
IDERA PHARMACEUTICALS, INC. (Filed by)
Form 425
View Filing
06/20/2018
8:53 PM
BioCryst Pharmaceuticals (Subject)
Form 425
View Filing
06/20/2018
4:12 PM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/20/2018
3:14 PM
BioCryst Pharmaceuticals (Subject)
GREAT POINT PARTNERS LLC (Filed by)
Form SC 13D/A
View Filing
06/11/2018
1:42 PM
BioCryst Pharmaceuticals (Subject)
IDERA PHARMACEUTICALS, INC. (Filed by)
Form 425
View Filing
06/11/2018
1:41 PM
BioCryst Pharmaceuticals (Subject)
Form 425
View Filing
06/07/2018
7:17 AM
BioCryst Pharmaceuticals (Subject)
IDERA PHARMACEUTICALS, INC. (Filed by)
Form 425
View Filing
06/07/2018
7:15 AM
BioCryst Pharmaceuticals (Subject)
Form 425
View Filing
06/06/2018
1:49 PM
BioCryst Pharmaceuticals (Filer)
Form CT ORDER
View Filing
06/05/2018
2:07 PM
BioCryst Pharmaceuticals (Issuer)
Sheridan William P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/05/2018
6:42 AM
BioCryst Pharmaceuticals (Subject)
Form 425
View Filing
06/04/2018
1:54 PM
BioCryst Pharmaceuticals (Issuer)
INGRAM ROBERT ALEXANDER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/04/2018
1:48 PM
BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/30/2018
4:11 PM
BioCryst Pharmaceuticals (Filer)
Form DEFM14A
View Filing
05/24/2018
3:00 PM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/21/2018
8:31 AM
BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/17/2018
8:25 AM
Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/10/2018
3:06 PM
BioCryst Pharmaceuticals (Filer)
Form DEFA14A
View Filing
05/10/2018
3:06 PM
BioCryst Pharmaceuticals (Filer)
Form DEF 14A
View Filing
05/09/2018
1:10 PM
BioCryst Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
05/09/2018
5:35 AM
BioCryst Pharmaceuticals (Subject)
Form 425
View Filing
05/08/2018
2:15 PM
BioCryst Pharmaceuticals (Subject)
Form 425
View Filing
05/08/2018
2:14 PM
BioCryst Pharmaceuticals (Subject)
Form 425
View Filing
05/08/2018
7:48 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/01/2018
7:33 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/10/2018
7:31 AM
BioCryst Pharmaceuticals (Subject)
Form 425
View Filing
04/10/2018
7:31 AM
BioCryst Pharmaceuticals (Subject)
IDERA PHARMACEUTICALS, INC. (Filed by)
Form 425
View Filing
04/02/2018
4:04 PM
BioCryst Pharmaceuticals (Subject)
IDERA PHARMACEUTICALS, INC. (Filed by)
Form 425
View Filing
04/02/2018
4:04 PM
BioCryst Pharmaceuticals (Subject)
Form 425
View Filing
04/02/2018
3:52 PM
BioCryst Pharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13D
View Filing
04/02/2018
11:59 AM
BioCryst Pharmaceuticals (Subject)
Form 425
View Filing
04/02/2018
11:58 AM
BioCryst Pharmaceuticals (Subject)
IDERA PHARMACEUTICALS, INC. (Filed by)
Form 425
View Filing
03/29/2018
2:40 PM
BioCryst Pharmaceuticals (Filer)
Form DEFM14A
View Filing
03/27/2018
10:50 AM
BioCryst Pharmaceuticals (Filer)
Form 10-K/A
View Filing
03/22/2018
3:06 PM
BioCryst Pharmaceuticals (Subject)
Form 425
View Filing
03/22/2018
3:06 PM
BioCryst Pharmaceuticals (Subject)
IDERA PHARMACEUTICALS, INC. (Filed by)
Form 425
View Filing
03/15/2018
8:25 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/12/2018
1:51 PM
BioCryst Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
03/08/2018
4:16 PM
BioCryst Pharmaceuticals (Subject)
IDERA PHARMACEUTICALS, INC. (Filed by)
Form 425
View Filing
03/08/2018
2:48 PM
Babu Yarlagadda S (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/02/2018
1:23 PM
BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/02/2018
1:21 PM
Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/02/2018
1:14 PM
BioCryst Pharmaceuticals (Issuer)
INGRAM ROBERT ALEXANDER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/02/2018
1:11 PM
BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/28/2018
10:11 AM
BioCryst Pharmaceuticals (Subject)
Form 425
View Filing
02/28/2018
7:31 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/27/2018
11:28 AM
BioCryst Pharmaceuticals (Subject)
Form 425
View Filing
02/27/2018
11:26 AM
BioCryst Pharmaceuticals (Subject)
Form 425
View Filing
02/27/2018
7:30 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/27/2018
7:01 AM
BioCryst Pharmaceuticals (Subject)
IDERA PHARMACEUTICALS, INC. (Filed by)
Form 425
View Filing
This page was last updated on 12/15/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel